Economy

Analysts Near-Term outlook: Integra LifeSciences Holdings Corporation (IART), Humana Inc. (HUM)

More important recent Edwards Lifesciences Corp (NYSE:EW) news were published by: Nasdaq.com which released: "Zacks.com featured highlights: SP Plus Corp, Edwards Lifesciences, Magna ..." on August 21, 2017, also Prnewswire.com published article titled: "Edwards Lifesciences To Present At The 12th Annual Wells Fargo Healthcare ...", Nasdaq.com published: "Why the Earnings Streak Will Continue for Edwards Lifesciences (EW)" on September 12, 2017. The fund owned 224,844 shares of the medical research company's stock after acquiring an additional 30,796 shares during the period.

Several other institutional investors have also bought and sold shares of IART. Jefferies Group LLC restated a buy rating and set a $115.00 price objective on shares of Edwards Lifesciences Corporation in a research report on Friday, June 30th. Ridgeworth Capital Management Llc sold 6,184 shares as Edwards Lifesciences Corp (EW)'s stock rose 25.80%. Finally, Veritable L.P. grew its holdings in shares of Edwards Lifesciences Corporation by 1.2% during the second quarter. Winslow Evans Crocker reported 96 shares or 0% of all its holdings. Following the completion of the transaction, the director now directly owns 44,772 shares in the company, valued at approximately $2,208,602.76. Riverhead Capital Management LLC grew its position in shares of Integra LifeSciences Holdings Corporation by 49.9% during the second quarter. The Ridgeworth Capital Management Llc holds 176,031 shares with $16.49M value, down from 182,215 last quarter.

IART has been the topic of several analyst reports. Oppenheimer Holdings has a "Buy" rating on the stock.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) share price decreased in the last trading session with a previous 52-week high of $56.42. UBS AG reiterated a "buy" rating and set a $60.00 price target (up from $48.00) on shares of Integra LifeSciences Holdings Corporation in a report on Friday, June 9th. Sell-side analyst recommendations point to a short term price target of $19.45 on the company shares. Six analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. Integra LifeSciences Holdings Corporation now has an average rating of "Buy" and a consensus target price of $47.15.

WARNING: "Oppenheimer & Co. Inc". Finally, BlackRock Fund Advisors increased its stake in shares of Integra LifeSciences Holdings Corporation by 8.6% in the third quarter. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and worldwide copyright and trademark law.

09/23/2016 - Integra LifeSciences Holdings Corporation had its "buy" rating reiterated by analysts at Argus. State of Tennessee Treasury Department owned about 0.11% of Edwards Lifesciences Corporation worth $26,585,000 as of its most recent SEC filing. The stock has a 50-day moving average price of $50.44 and a 200 day moving average price of $48.38. Integra LifeSciences Holdings Corporation has a 1-year low of $29.38 and a 1-year high of $45.87. The company has market cap of $4.05 billion.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) last announced its quarterly earnings results on Wednesday, July 26th. Looking ahead to earnings forecasts, for the running fiscal period, Wall Street analysts have anticipated that the company will report 0.47 earnings per share.

Integra LifeSciences Holdings Corporation had its "overweight" rating reiterated by analysts at Cantor Fitzgerald. The firm had revenue of $842.00 million during the quarter, compared to analyst estimates of $839.16 million. During the same period previous year, the business earned $0.40 earnings per share. The firm's revenue was up 13.2% on a year-over-year basis. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,534 shares of the life sciences company's stock valued at $107,000 after purchasing an additional 1,751 shares in the last quarter. The stock was purchased at an average price of $49.33 per share, for a total transaction of $249,116.50. Alps Advisors Inc. now owns 5,102 shares of the medical research company's stock valued at $603,000 after buying an additional 14 shares in the last quarter. The disclosure for this sale can be found here. In the last 90 days, insiders have bought 17,550 shares of company stock valued at $864,842. With respect to its data and voice communications services, the Company owns and operates a carrier-grade, MultiProtocol Label Switching (MPLS)-enabled fixed wireless, Internet protocol (IP) communications network in Canada targeting businesses that require Internet access and data connectivity services.

For this year, Edwards Lifesciences Corporation (NYSE:EW) is performing 21.13%. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.



Like this

Latest


19 September 2017
OMNOVA Solutions Inc. (NYSE:OMN) Experiences Heavy Trading Volume
The value of the investment in OMN decreased from $1,617,000 to $1,300,000 a change of 19.6% for the reporting period. OMNOVA Solutions (NYSE:OMN) previously released its periodic earnings reports on early Wed, Jun 28th.

19 September 2017
Navy plans to use Xbox controllers for new periscope systems
The current periscope joysticks, built specifically for the advanced attack subs, cost almost $38,000. The Navy plans on implementing the new Xbox 360 hardware on future Virginia-class submarines.

19 September 2017
Apple's Venmo-like money transfers will arrive after iOS 11
Pay and get paid right in Messages, or tell Siri to pay someone, using the credit and debit cards they have in Wallet. Apple Pay Cash will allow Apple device users to transfer money between each other within Messages or through Siri.

19 September 2017
Zone of the Enders: The 2nd Runner remaster headed to PS4
We would like to make Zone of The Enders 3 just as the fans do, but we don't have the manpower required to make such a game. Plans for a third major ZOE game were cancelled after the HD re-release of ZOE 1 and 2 did not attract enough sales.

19 September 2017
MACOM Technology Solutions Hold (MTSI) - Barclays Maintains Rating And Raises Price Target
Barclays Capital maintained MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI) on Friday, March 11 with "Overweight" rating. MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI) has risen 62.84% since September 17, 2016 and is uptrending.

19 September 2017
Square Enix announces Left Alive for PS4 and PC
Hashimoto has previous worked with Square Enix on Final Fantasy VII: Advent Children, and Final Fantasy XV: Kingsglaive. Square Enix announced their newest game, Left Alive , during Tokyo Game Show 2017 in a first look teaser trailer.

19 September 2017
Bitter: Hillary Won't Rule Out Contesting 2016 Result
Asked during the final presidential debate if he would accept second place, he responded: 'I will look at it at the time'. She outright says, "I just don't think we have a mechanism" to contest it.

19 September 2017
Flipkart Big Billion Day Sale: Smartphones that you will get at discount
Amazon India also announced that its Great Indian Festival Sale starting September 21 and will continue till September 24. Heavy discounts on products like TVs, laptops and home appliances are being promised.

19 September 2017
Overnight Ratings: Emmy Awards Ceremony Stays Low In 2017
This moment in the show was also the most gifable, because the star's reactions in the audience were of sheer surprise. Emmy Awards host Stephen Colbert has taken a jab at President Donald Trump in his opening monologue.

19 September 2017
Sean Spicer helps Stephen Colbert mock Trump at the Emmys
I mean, who did this? "It's so great that we can embrace someone who used a powerful position to abuse the press and lie to America".



Recommended